Novartis Unit Seeks £11.3M Damages Over Invalidated Patent
By Bonnie Eslinger ( October 8, 2020, 9:12 PM BST) -- A Novartis subsidiary slapped a Pfizer unit with a claim in the U.K. for more than £11.3 million ($14.6 million) in damages it says it suffered from infringement litigation over a patent for the blockbuster drug Lyrica that was later invalidated by the U.K. Supreme Court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.